FDA — authorised 26 November 1973
- Application: NDA017381
- Marketing authorisation holder: KING PHARMS LLC
- Local brand name: SILVADENE
- Indication: CREAM — TOPICAL
- Status: approved
🇺🇸 Silvadene in United States
FDA authorised Silvadene on 26 November 1973
Marketing authorisations
FDA — authorised 25 February 1982
- Application: NDA018578
- Marketing authorisation holder: DR REDDYS
- Local brand name: SSD AF
- Indication: CREAM — TOPICAL
- Status: approved
FDA — authorised 23 December 1985
- Application: NDA018810
- Marketing authorisation holder: THEPHARMANETWORK LLC
- Local brand name: THERMAZENE
- Indication: CREAM — TOPICAL
- Status: approved
FDA — authorised 30 November 1989
- Application: NDA019608
- Marketing authorisation holder: FRANKLIN PHARMS
- Local brand name: SILDAFLO
- Indication: DRESSING — TOPICAL
- Status: approved
FDA
- Status: approved
Silvadene in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in United States
Frequently asked questions
Is Silvadene approved in United States?
Yes. FDA authorised it on 26 November 1973; FDA authorised it on 25 February 1982; FDA authorised it on 23 December 1985.
Who is the marketing authorisation holder for Silvadene in United States?
KING PHARMS LLC holds the US marketing authorisation.